From BugSigDB

A synthetic form of the Ras peptide containing a point mutation at position 12 (glycine to cysteine) with potential antineoplastic activity. Vaccination with this peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for this Ras mutation, resulting in decreased tumor growth. (NCI04)
  • 3,3',4,4'-tetrachloro-1,1'-biphenyl
  • 3,4,3',4'-Tetra coplanar polychlorinated biphenyl
  • C12H6Cl4
  • Clc1ccc(cc1Cl)-c1ccc(Cl)c(Cl)c1
  • InChI=1/C12H6Cl4/c13-9-3-1-7(5-11(9)15)8-2-4-10(14)12(16)6-8/h1-6H
  • Ras (sub 5-17) Peptide (C12)
  • Ras Peptide CYS